Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IV iron versus erythropoietin versus standard care before elective hip or knee arthroplasty
NL-OMON41610Not yet recruiting
- Sponsor
- no sponsor
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose, epoetin alfa and Iron in anaemia (3 arms), sponsored by no sponsor. Primary endpoint: Rate of transfused patients. Planned start Jan 2013; status: not yet recruiting.
02
Drugs
ferric carboxymaltoseepoetin alfaIron
03
Conditions
anaemia
Beyond the preview
Go deeper on NL-OMON41610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41610.